UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as specified in its Charter)
| (State or other jurisdiction of incorporation) |
(Commission File No.) |
(IRS Employer Identification No.) |
(Address of principal executive offices)
(Registrant’s Telephone Number)
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
| Common | HMLA | OTC Pink |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR 240.12b-2)
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act
Himalaya Technologies, Inc. is referred to herein as “Himalaya”, “we”, “us”, or “the Company”.
Item 1.01 Entry into a Material Definitive Agreement.
On August 12, 2024, we signed a partnership and joint development agreement with InsureTEK, Inc. ("InsureTEK") including a four-year license of a proprietary technology platform using Artificial Intelligence ("AI") and Internet of Things ("IoT") to provide loss control services to commercial real estate ("CRE"), government and industrial buildings, and multi-family and flex use properties. As consideration, we agreed to issue InsureTEK 200,000 Series B Preferred shares and a $250,000 7.5% two-year junior note convertible into common stock under certain terms up to a $50,000,000 diluted equity valuation. A redacted copy of the partnership agreement is included herein as Exhibit 10.1. Copies of the note purchase agreement and convertible note agreement both executed August 31, 2024 are included herein as Exhibits 10.2 and 10.3, respectively. A press release with additional information issued on August 26, 2024 is included herein as Exhibit 99.1
Item 9.01. Exhibits
| (10, 99) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: |
| Exhibit No. | Description | |
| 10.1 | Himalaya Technologies, Inc. InsureTEK Tech License and Partnership Agreement – 08/12/2024 | |
| 10.2 | Himalaya Technologies, Inc. InsureTEK Tech Note Purchase Agreement – 08/31/2024 | |
| 10.3 | Himalaya Technologies, Inc. InsureTEK Tech Convertible Note – 08/31/2024 | |
| 99.1 | Himalaya Technologies, Inc. Press Release – 08/26/2024 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HIMALAYA TECHNOLOGIES, INC. | ||
| Date: September 3, 2024 | By: | /s/ Vikram Grover |
| Vikram Grover | ||
| Chief Executive Officer | ||